Skip to main content
logo
Alamar Biosciences, Inc. (ALMR)
NASDAQ: ALMR · Real-Time Price · USD
27.11
+0.04 (0.15%)
At close: Aug 4, 2026, 4:00 PM EDT
27.89
+0.78 (2.89%)
After-hours: Aug 4, 2026, 4:26 PM EDT

Alamar Biosciences Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Mar '26 Dec '25 Dec '24
Cash & Equivalents
64.593026.77
Short-Term Investments
--52.59
Cash & Short-Term Investments
64.593079.36
Cash Growth
-18.61%-62.19%-
Accounts Receivable
19.5212.756.65
Inventory
39.9338.4814.41
Other Current Assets
17.4313.476.28
Total Current Assets
141.4794.71106.7
Net Property, Plant & Equipment
36.1436.6335.1
Other Intangible Assets
1.841.992.04
Other Long-Term Assets
76.675.67
Total Assets
186.45139.99149.51

Liabilities

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Mar '26 Dec '25 Dec '24
Accounts Payable
5.645.876.19
Accrued Expenses
16.8115.768.49
Current Portion of Leases
1.62.11.91
Total Current Liabilities
24.0523.7316.59
Long-Term Debt
74.979.81-
Long-Term Leases
28.9829.5631.19
Other Long-Term Liabilities
1.530.850.15
Total Long-Term Liabilities
105.4840.2231.34
Total Liabilities
129.5363.9547.93

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Mar '26 Dec '25 Dec '24
Common Stock
000
Additional Paid-in Capital
12.119.895.4
Accumulated Other Comprehensive Income
-0.08-0.070.15
Retained Earnings
-190.1-168.78-138.96
Total Common Shareholders' Equity
-178.07-158.95-133.41
Minority Interest
235235235
Shareholders' Equity
56.9376.04101.59
Total Liabilities & Equity
186.45139.99149.51

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Mar '26 Dec '25 Dec '24
Total Debt
105.5541.4733.1
Net Cash (Debt)
-40.96-11.4746.26
Net Cash Growth
---
Net Cash Per Share
-3.18-0.993.89
Book Value
-178.07-158.95-133.41
Book Value Per Share
-13.83-13.77-11.22
Tangible Book Value
-179.91-160.94-135.46
Tangible Book Value Per Share
-13.98-13.94-11.39
SEC Filings: 10-K · 10-Q